Accelerate actionable business insights from trusted and secure data
Enterprise-grade insights for emerging pharma
Empower intelligent interactive decision making
Optimize sales team customer engagement and drive higher commercial success
Leverage next best action (NBA) driven omnichannel customer engagement
Democratize marketing analytics to achieve strategic performance
Enterprise-grade insights for emerging pharma.
Latest Insights
White Paper
Dynamic Activity Planning: Empowering the Field Force to Elevate Customer Engagement
Case Study
Transforming Medical Inquiries-Based Insights With Innovative Generative AI Solutions
Latest Insights
White Paper
Dynamic Activity Planning: Empowering the Field Force to Elevate Customer Engagement
Latest Insights
Case Study
Transforming Medical Inquiries-Based Insights With Innovative Generative AI Solutions
Latest Insights
Case Study
Transforming Medical Inquiries-Based Insights With Innovative Generative AI Solutions
Latest Insights
Latest Insights
Latest Insights
Latest Insights
Case Study
Transforming Medical Inquiries-Based Insights With Innovative Generative AI Solutions
Guiding, enabling, and leading clients today on best-in-class journeys that unlock the power of GenAI.
Learn MoreMake the potential of Big Data a reality driving the business and patient outcomes.
Learn MoreAnything, Anywhere, Anytime – with cloud, the sky is the limit.
Learn MoreUnlock future business values & gain efficiencies with AI/ML technologies.
Learn MoreIndustries
Software that delivers life sciences data to insights to planning to operations.
Learn MoreLatest Insights
Latest Insights
Latest Insights
Latest Insights
Case Study
Transforming Medical Inquiries-Based Insights With Innovative Generative AI Solutions
Case Study
Revolutionizing Information Access and Decision-Making With Generative AI for a Top 5...
Case Study
75% Cost Savings From Natural Language Processing and Generative AI While Evaluating...
Latest Insights
Latest Insights
Latest Insights
Media Wall
India Has the Potential to Emerge as a Frontrunner in Analytics, Offering Unparalleled...
THE AXTRIA COLLECTIVE
Get the latest topics, trends, and high-value insights with thought-provoking content from the ever-changing landscape of the life sciences industry.
June 2024
Gen AI's role in evaluating patient experiences, impact of IRA on RWE, and more.
Passionate people transforming patient lives
Making a positive impact on the environment
We are Individually diverse & collectively inclusive
Delivering value through an ecosystem of partners
Connect with us – We’re ready to talk opportunities
Latest announcement and media coverage
Axtria Inc. 300
Connell Drive, 5th Floor,
Berkeley Heights, NJ 07922
United States
+1-877-929-8742
connect@axtria.com
Contact Us
Axtria Inc. 300
Connell Drive, 5th Floor,
Berkeley Heights, NJ 07922
United States
+1-877-929-8742
connect@axtria.com
Copyright © 2023 Axtria. All Rights Reserved.
Axtria Cookie Policy & Privacy Statement.
Home Improving Targeting And Call Plans With Inclusion Of Managed Care And Health System Considerations
In order for pharmaceutical companies to achieve a favorite formulary position, they are providing more discounts and rebates to payers. In addition, the key account management (KAM) team is also investing significant effort with HS/IDNs for influencing treatment guidelines. Manufacturers must consider the influence of payers and providers on treatment decisions and reconfigure their strategy and operations. The objective of this webinar session is to provide an overview of the HCP scoring and segmentation approach based on payer and IDN influence, and how HCP scoring can be leveraged to optimize call plans.
Rakesh has 13+ years of professional experience, working in the areas of Commercial Operations, Managed Markets, business reporting solutions and ad-hoc analytics across top pharmaceutical companies. At Axtria, he has been leading engagements and delivering projects in the space of call planning & incentive compensation across multiple clients.
Anuj brings 8+ years of experience in consulting, data analytics, and sales operations. He has rich experience in incentive compensation quota setting, call planning, drug sales forecasting, and business intelligence solutions in managed markets. At present, he is working on targeting and call planning for orphan drugs.